AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

ROSUVASTATIN 40 Mg ;

9 registrations across 1 African market— 9 active

Markets with ROSUVASTATIN 40 Mg ;

Recent registrations

Brand / ProductMarketHolderStatusExpires
Bemastrim 40 mg
Film Coated Tablets
🇪🇬EgyptThe Tenth of Ramadan for Pharmaceutical Industries & Diagnostic Reagents "RAMEDA"active
Novistoric 40 mg
Film Coated Tablets
🇪🇬EgyptFUTURE PHARMACEUTICAL INDUSTRIES-EGYPTactive
Gypravastin 40 mg
Film Coated Tablets
🇪🇬EgyptGypto Pharma for Pharmaceutical Manufacturing and Trading - GYPTOactive
Cholerose 40 mg
Film Coated Tablets
🇪🇬EgyptMarcyrl pharmaceutical industries - MPIactive
Epirovastin ® 40 mg
Film Coated Tablets
🇪🇬EgyptEgyptian International Pharmaceutical Industries Company (EIPICO)active
Epirovastin ® 40 mg
Film Coated Tablets
🇪🇬EgyptEgyptian International Pharmaceutical Industries Company (EIPICO)active
Gypravastin 40 mg
Film Coated Tablets
🇪🇬EgyptGypto Pharma for Pharmaceutical Manufacturing and Trading - GYPTOactive
Bemastrim 40 mg
Film Coated Tablets
🇪🇬EgyptThe Tenth of Ramadan for Pharmaceutical Industries & Diagnostic Reagents "RAMEDA"active
Novistoric 40 mg
Film Coated Tablets
🇪🇬EgyptFUTURE PHARMACEUTICAL INDUSTRIES-EGYPTactive

ROSUVASTATIN 40 Mg ; in Africa — Regulatory Overview

ROSUVASTATIN 40 Mg ; is registered across 1 African markets with 9 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Egypt. AfricaRegulatory refreshes this data daily from official government sources.

Of the 9 registrations, 9 (100%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.